Months 10-12 Long-term planning Focus on sustaining whole-body health and consider next steps for your GLP-1 therapy
Monotherapy-Dr Prabhat Ranjan The combination therapy of metformin and GLP-1 receptor agonists (GLP-1 RAs) demonstrates superior safety over monotherapy, while revealing novel adverse events and demographic-specific risk patterns, a large-scale pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) has reported
Check back often to read about the latest techniques and state-of-the-art technologies in skin health, cosmetic procedures, anti-aging, body sculpting, hair loss treatment, fat loss, and more
Also read: 5 Lifestyle Factors For A Younger Heart (02/05/25) Neuroprotection is another area where benefits of using GLP1s are starting to generate evidence, specifically lower risk of Alzheimers, although data is still early
Insulin sensitivity should be monitored, particularly in subjects with pre-existing insulin resistance or metabolic syndrome